CorVel Corporation (CRVL) Stock

CorVel Corporation (CRVL) is a Financials stock trading at $70.39 (as of 2026-09-02), with a market capitalization of $3.52B and a trailing P/E of 30.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions for employers, third-party administrators, insurance companies, and government agencies, including medical fee auditing, preferred provider and reimbursement services, utilization review, pharmacy and directed care, and independent medical examinations. It also offers claims and case management services such as nurse triage, utilization management, vocational rehabilitation, and life care planning.

Understand CorVel Corporation: how it makes money

CorVel runs the claim-management and cost-containment layer behind workers' comp, auto, and liability insurance, charging insurers and TPAs fees for auditing medical bills and steering care networks. Growth is embedded: revenue compounds inside existing partner relationships rather than requiring a constant stream of new-logo wins.

Revenue is a per-claim fee, and AI is compressing the labor cost behind that fee, so each claim processed becomes incrementally more profitable over time.

Business quality (Solid): Solid recurring-revenue analytics name with a debt-free balance sheet, 27% ROE, and sticky clients, though the 32x multiple already prices a fair amount of optimistic AI-driven margin expansion.

Valuation: At 32× earnings, CRVL trades 147% above the Insurance average (13×).

Bull case

  • Embedded growth in existing accounts: Management says existing-partner expansion is driving organic growth across both major operating segments. The embedded-growth model means revenue compounds within the installed base rather than depending on a constant drip of new-logo acquisition.
  • AI compresses the cost base: Management notes AI-enabled automation could improve operating leverage and accelerate product delivery. With Cost of Revenues at $180M, roughly 60% of revenue, even modest automation gain flows disproportionately into the 17% operating-margin line.
  • Debt-free optionality for M&A: Management highlights a debt-free balance sheet that supports product expansion and acquisition opportunities. In a niche where network coverage and scale matter, bolt-on deals can extend reach without diluting existing equity.

Bear case

  • Payer pressure caps per-claim fees: Management acknowledges elevated payer pricing pressure and recurring savings demands on service operations. If insurers squeeze the fee per claim, revenue compresses even if the cost side improves via automation.
  • 32x multiple prices perfection: The stock trades at P/E 32.2x versus an Insurance industry average of 13x, a 147% premium. That gap assumes the AI-driven margin story plays out on schedule and 11% growth sustains without stumbles.
  • Labor scarcity undermines AI timeline: Management flags that industry-wide labor shortages are making experienced professionals harder to recruit and retain. If the AI deployment meant to offset labor gaps slips, the near-term cost-compression catalyst weakens.
Valuation — source: SEC EDGAR (first-party)
Price$70.39
Market Cap$3.52B
P/E Ratio30.5
EV / EBITDA17.8
Price / Book8.61
Price / Sales3.58
FCF Yield3.1%
DCF Value (model)$56.14
DCF Upside vs Price-20.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$958.53M
Net Margin11.5%
Revenue Growth (YoY)10.7%
EPS Growth (YoY)18.9%
FCF Growth (YoY)8.9%
Financial Health — source: SEC EDGAR
Altman Z-Score13.39 (safe)
Valuation vs Sector & Industry
Stock P/E30.5
Sector P/E (Financials)14.9
Industry P/E (Insurance)12.1
vs Sector104.5%
vs Industry151.2%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($266.52M)
Institutional Holders Tracked10
Company
SectorFinancials
IndustryInsurance
CEOMichael G. Combs
Employees4,870
CountryUS
IPO Date1991-06-28

CorVel Corporation earnings call transcripts

  • CRVL Q3 FY26 earnings call transcript (reported 2026-02-03) · analysis
  • CRVL Q2 FY26 earnings call transcript (reported 2025-11-04) · analysis
  • CRVL Q2 FY23 earnings call transcript (reported 2022-11-01) · analysis
  • CRVL Q1 FY23 earnings call transcript (reported 2022-08-02) · analysis

All CRVL earnings calls

Related Companies (Insurance; 8 comparable insurers)

  • CRAWFORD & CO (CRD)
  • Clover Health Investments, Corp. (CLOV)
  • Alignment Healthcare, Inc. (ALHC)
  • Oscar Health, Inc. (OSCR)
  • Stewart Information Services Corporation (STC)
  • Investors Title Company (ITIC)
  • KINGSWAY Corp (KWY)
  • Molina Healthcare, Inc. (MOH)
CRVL earnings history · CRVL institutional & insider holders · CRVL KPIs & operating metrics · CRVL financials · CRVL investor presentations & press releases · CRVL SEC filings · CRVL peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-09-02.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.